Status:
COMPLETED
Hyperlactatemia During and After Tumorcraniotomy
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Hyperlactatemia
Brain Tumor
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to investigate the association between hyperlactatemia and neurological disability, length-of-stay and mortality in patients who undergo tumorcraniotomy. The risk factors that induce l...
Detailed Description
Hyperlactatemia is a frequent occurrence in brain tumor surgery. The existing studies, however, are all retrospective, reporting varying effects on clinical outcome. One study reported new neurologica...
Eligibility Criteria
Inclusion
- Age \>/= 18 years
- Must undergo elective tumor craniotomy
- Understand oral and written Danish
Exclusion
- Adults with incapacity
- Stereotactic biopsy
- Lack of informed and signed consent to participate in study
Key Trial Info
Start Date :
July 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 18 2022
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT04410315
Start Date
July 28 2020
End Date
February 18 2022
Last Update
August 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neuroanesthesiology, Rigshospitalet
Copenhagen, Denmark